Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-β/Smad signaling pathway

Fang Dou,Yi Ding,Cheng Wang,Jialin Duan,Wenjun Wang,Hang Xu,Xian Zhao,Jingwen Wang,Aidong Wen
DOI: https://doi.org/10.1016/j.bcp.2020.114079
IF: 6.1
2020-10-01
Biochemical Pharmacology
Abstract:<p>Renal interstitial fibrosis (RIF) is a major pathological feature of chronic kidney disease at middle and end stages. Chrysophanol (CP), 1,8-dihydroxy-3-methyl-9,10-anthraquinone, is an anthraquinone isolated from <em>Rheum palmatum</em> L.with a variety of pharmacological activities including the suppression of RIF. However, the effect of CP on renal fibrosis and its potential mechanism have not been elucidated. We conducted a comprehensive study by determining the expression levels of fibrotic markers and proteins including TGF-β1, α-SMA, and Smad3 related to transforming growth factor-beta/Smad (TGF-β/Smad) pathway in unilateral ureteral obstruction (UUO) mice and TGF-β1-stimulated HK-2 cells with the treatment of CP using western blotting and RT-qPCR analyses. Using small interfering RNA and co-immunoprecipitation, we evaluated the influences of CP on the interactions between Smad3 and Smad7 proteins and also on TGF-β RI and TGF-βR II. We found that CP administration significantly ameliorated UUO-induced kidney damage by reversing abnormal serum and urine biochemical parameters and decreasing the production of fibrotic markers including collagen I, collagen III, fibronectin, and α-SMA. Our results showed that TGF-β1 and phospho-Smad3 (p-Smad3) expression was significantly down-regulated and Smad7 expression was up-regulated by CP in UUO mice compared to the model group; however, the expression of Smad2, Smad4, and TGF-β receptors was not affected. Furthermore, CP modulated these fibrotic markers as well as p-Smad3 and Smad7 in TGF-β1-induced HK-2 cells. The inhibitory effect of CP was markedly reduced in TGF-β1-treated HK-2 cells transfected with Smad3 siRNA. Additionally, co-immunoprecipitation analysis indicated that CP blocked the interaction between Smad3 and TGF-β receptor I to suppress p-Smad3 expression. These findings demonstrated that CP alleviated RIF by inhibiting Smad3 phosphorylation, which provides a molecular basis for a new drug candidate for the treatment of RIF.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the effect of chrysophanol (CP) on renal interstitial fibrosis (RIF) and its underlying mechanisms. Specifically, the researchers hope to experimentally verify whether CP can improve renal interstitial fibrosis caused by unilateral ureteral obstruction (UUO) by inhibiting the transforming growth factor - β/Smad (TGF - β/Smad) signaling pathway. ### Main research contents: 1. **Experimental design**: - Use the UUO mouse model and TGF - β1 - stimulated human proximal tubular epithelial cell line (HK - 2 cells) to evaluate the effect of CP on RIF. - Detect the expression levels of fibrosis markers and proteins related to the TGF - β/Smad signaling pathway by methods such as Western Blotting and RT - qPCR. - Use small interfering RNA (siRNA) technology to knockdown Smad3 expression to further verify the mechanism of action of CP. - Analyze the effect of CP on the interaction between Smad3 and TGF - β receptor I (TGF - βR I), TGF - βR II and Smad7 by co - immunoprecipitation. 2. **Main findings**: - CP significantly improved the renal function of UUO mice, decreased the levels of serum creatinine (Scr) and blood urea nitrogen (BUN), increased the urine volume, and partially restored the damaged kidney structure. - CP significantly down - regulated the expression of fibrosis markers (such as collagen I, collagen III, fibronectin, α - smooth muscle actin (α - SMA)) in UUO mice. - CP inhibits the activation of the TGF - β/Smad signaling pathway by inhibiting the phosphorylation of Smad3 and up - regulating the expression of Smad7. - In TGF - β1 - induced HK - 2 cells, CP also showed an anti - fibrosis effect, and this effect was significantly weakened after Smad3 was knocked down. - The co - immunoprecipitation results showed that CP inhibited the binding of Smad3 to TGF - βR I, TGF - βR II and SARA, and at the same time promoted the binding of Smad7 to TGF - βR I and Smurf2. ### Conclusion: This study demonstrated that CP alleviates renal interstitial fibrosis by inhibiting Smad3 phosphorylation in the TGF - β/Smad signaling pathway. These findings provide a molecular basis for the development of new drugs for the treatment of RIF.